Literature DB >> 33255791

Self-Assembled Multi-Epitope Peptide Amphiphiles Enhance the Immune Response against Enterovirus 71.

Yu-Gyeong Kim1, Yunsu Lee1, Joo Hee Kim1, Sun-Young Chang1, Jong-Wha Jung2, Woo-Jae Chung3, Hyo-Eon Jin1,4.   

Abstract

Subunit vaccines consist of non-genetic material, such as peptides or proteins. They are considered safe because they have fewer side effects; however, they have low immunogenicity when used alone. We aimed to enhance the immune response of peptide-based vaccines by using self-assembled multimeric peptide amphiphiles (PAs). We designed two epitope PAs by conjugating epitope peptides from Enterovirus 71 (EV71) virus particle (VP) 1 and VP3 capsid proteins with different fatty acid chain lengths (VP1PA and VP3PA). These PAs self-assembled into supramolecular structures at a physiological pH, and the resulting structures were characterized using atomic force microscopy. Multi-epitope PAs (m-PAs) consisted of a 1:1 mixture of VP1PA and VP3PA solutions. To evaluate immunogenicity, m-PA constructs were injected with adjuvant subcutaneously into female Balb/c mice. Levels of antigen-specific immunoglobulin G (IgG) and IgG1 in m-PA-injected mice serum samples were analyzed using ELISA and Western blotting. Additionally, cytokine production stimulated by each antigen was measured in splenocytes cultured from immunized mice groups. We found that m-PA showed improved humoral and cellular immune responses compared to the control and peptide groups. The sera from m-PA immunized mice group could neutralize EV71 infection and protect host cells. Thus, self-assembled m-PAs can promote a protective immune response and can be developed as a potential platform technology to produce peptide vaccines against infectious viral diseases.

Entities:  

Keywords:  Enterovirus 71; immune stimulator; peptide amphiphile; vaccine; viral infectious disease

Year:  2020        PMID: 33255791      PMCID: PMC7760352          DOI: 10.3390/nano10122342

Source DB:  PubMed          Journal:  Nanomaterials (Basel)        ISSN: 2079-4991            Impact factor:   5.076


  33 in total

1.  Pros and cons of VP1-specific maternal IgG for the protection of Enterovirus 71 infection.

Authors:  Young-In Kim; Jae-Hyoung Song; Bo-Eun Kwon; Ha-Neul Kim; Min-Duk Seo; KwiSung Park; SangWon Lee; Sang-Gu Yeo; Mi-Na Kweon; Hyun-Jeong Ko; Sun-Young Chang
Journal:  Vaccine       Date:  2015-10-31       Impact factor: 3.641

2.  Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants.

Authors:  Ulrich Schroeder; Alexandra Graff; Sabine Buchmeier; Per Rigler; Unai Silvan; David Tropel; Brigitte M Jockusch; Ueli Aebi; Peter Burkhard; Cora-Ann Schoenenberger
Journal:  J Mol Biol       Date:  2008-11-25       Impact factor: 5.469

3.  Edward Jenner's inquiry after 200 years

Authors: 
Journal:  BMJ       Date:  1999-02-06

Review 4.  The history of MF59(®) adjuvant: a phoenix that arose from the ashes.

Authors:  Derek T O'Hagan; Gary S Ott; Gary Van Nest; Rino Rappuoli; Giuseppe Del Giudice
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

Review 5.  The role of antibody and complement in the control of viral infections.

Authors:  N R Cooper; G R Nemerow
Journal:  J Invest Dermatol       Date:  1984-07       Impact factor: 8.551

Review 6.  Recent Advances in Subunit Vaccine Carriers.

Authors:  Abhishek Vartak; Steven J Sucheck
Journal:  Vaccines (Basel)       Date:  2016-04-19

Review 7.  Enterovirus 71 infection and vaccines.

Authors:  Eun-Je Yi; Yun-Ju Shin; Jeong-Hwan Kim; Tae-Gyun Kim; Sun-Young Chang
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25

Review 8.  Vaccine Adjuvants: from 1920 to 2015 and Beyond.

Authors:  Alberta Di Pasquale; Scott Preiss; Fernanda Tavares Da Silva; Nathalie Garçon
Journal:  Vaccines (Basel)       Date:  2015-04-16

9.  Oral immunization with recombinant enterovirus 71 VP1 formulated with chitosan protects mice against lethal challenge.

Authors:  Fushun Zhang; Chunsheng Hao; Shuo Zhang; Aqian Li; Quanfu Zhang; Wei Wu; Lin Liu; Chuan Li; Mifang Liang; Xiuling Li; Dexin Li
Journal:  Virol J       Date:  2014-05-06       Impact factor: 4.099

10.  Antiviral activity of quercetin 7-rhamnoside against porcine epidemic diarrhea virus.

Authors:  Hwa-Jung Choi; Jin-Hee Kim; Choong-Hwan Lee; Young-Joon Ahn; Jae-Hyoung Song; Seung-Hwa Baek; Dur-Han Kwon
Journal:  Antiviral Res       Date:  2008-11-06       Impact factor: 5.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.